Q32 Bio Inc. (NASDAQ: QTTB) AI-Powered Stock Analysis
See how Q32 Bio Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
QTTB●NASDAQ
HealthcareBiotechnology
$16.49
$0.33(2.07%)
U.S. Market opens in 10h 37m
Q32 Bio Inc. (NASDAQ: QTTB) AI-Powered Stock Analysis
See how Q32 Bio Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerQ32 Bio Inc. (NASDAQ: QTTB) Stock Overall Grade
Q32 Bio Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Q32 Bio Inc.'s overall NASDAQ stock rating.
Forecast
C+Score
58/100Financial Growth
A+Score
95/100Fundamental Growth
BScore
65/100Key Ratios
AScore
85/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
B+Score
75/100Q32 Bio Inc. (NASDAQ: QTTB) AI-Powered Stock Analysis
On the NASDAQ, QTTB demonstrates Good performance with an overall Forecast Score of 58/100 (C+), reflecting weak confidence in its potential. Financial Growth (95/100, A+) and Fundamental Growth (65/100, B) highlight its stability, while Key Ratios (85/100, A) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (75/100, B+) suggests High divergence in outlook.(NASDAQ: QTTB) Component Analysis Explained
Understand the key factors behind each Q32 Bio Inc. (NASDAQ: QTTB) stock grade, including financials, comparisons, and forecasts.